Shaping gene expression in activated and resting primary macrophages by IL-10

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2253-2263

  Lang, Roland ^a   Patel, Divyen ^a   Morris, John J ^a   Rutschman, Robert L ^a   Murray, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE EXPRESSION; GENE INDUCTION; GENE NUMBER; GENE REPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

EID: 0036721716     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2253     Document Type: Article

References (44)

1. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes
2. Interleukin-10 and the interleukin-10 receptor
3. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease: The interleukin 10 inflammatory bowel disease cooperative study group
4. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
5. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding
6. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology
7. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes
8. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10
9. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes
10. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
11. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of stat3 in macrophages and neutrophils
12. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
13. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10
14. Interleukin-10-deficient mice develop chronic enterocolitis
15. Cutting edge: Stat6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes
16. Stereotyped and specific gene expression programs in human innate immune responses to bacteria
17. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase
18. Human macrophage activation programs induced by bacterial pathogens
19. Interleukin-10 inhibits expression of both interferon α- and interferon γ-induced genes by suppressing tyrosine phosphorylation of Stat1
20. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ
21. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs
22. Overexpression of metallothionein-II sensitizes rodent cells to apoptosis induced by DNA cross-linking agent through inhibition of NF-κB activation
23. NF-κB-inducible Bcl-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence
24. Gadd45γ mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector Th1 cells
25. Activation of MEK-1 and SEK-1 by Tp1-2 proto-oncoprotein, a novel MAP kinase kinase kinase
26. The proto-oncogene cot kinase participates in CD3/CD28 induction of NF-κB acting through the NFκB-inducing kinase and IκB kinases
27. TNF-α induction by LPS is regulated posttranscriptionally via a Tp12/ERK-dependent pathway
28. Molecular cloning and characterization of NFIL3a, a transcriptional activator of the human interleukin-3 promoter
29. Transcriptional repression by a novel member of the bZIP family of transcription factors
30. Other functions, other genes: Alternative activation of antigen-presenting cells
31. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines
32. Stat6-dependent substrate depletion regulates nitric oxide production
33. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide
34. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells
35. + T cells correlates with Th1/Th2 phenotype
36. Opening Pandora's SOCS box - A tale of destruction and degradation
37. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
38. Socs3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP-2 recruitment site of gp130
39. Interleukin-6-type cytokine signalling through the gp130/Jak/Stat pathway
40. Socs3 is essential in the regulation of fetal liver erythropoiesis
41. Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages
42. Interleukin-10 receptor signaling through the Jak-Stat pathway: Requirement for two distinct receptor-derived signals for anti-inflammatory action
43. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways
44. Proinflammatory effects of IL-10 during human endotoxemia